Prelude Capital Management’s Aclaris Therapeutics ACRS Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-11,791	Closed	-$18K	–	975
2025 Q1	$18K	Sell	11,791 -94,560	-89%	-$145K	﹤0.01%	1043
2024 Q4	$264K	Buy	+106,351	New	+$264K	0.02%	743
2020 Q3	–	Sell	-375	Closed	-$1K	–	1319
2020 Q2	$1K	Buy	+375	New	+$1K	﹤0.01%	1252